Hassanen EI, Tohamy AF, Issa MY, Ibrahim MA, Farroh KY, Hassan AM. Int J Nanomedicine. 2019;14:8905-8922.
An error during the preparation of Figures 6 and 7 led to the inadvertent creation of duplicate regions within multiple images from these figures on pages 8916 and 8917, respectively. The journal wishes to apologise for this error. The correct versions of Figures 6 and 7 are as follows.
Figure 6 Immunohistochemical expression of caspase-3 and NF-ĸB protein in the liver sections in different groups showing (A and B) mild to negative Caspase-3 and NFĸB protein expression in control negative group. (C and D) Strong positive caspase-3 and extensive nuclear translocation of NF-ĸB protein within hepatocytes in the group intoxicated with CuO-NPs. (E and F) Moderate positive caspase-3 and NF-ĸB protein expression in the group pretreated with 1 mL/kg bwt PJ. (G and H) Mild to negative caspase-3 and NF-ĸB protein expression in the group treated with 3 mL/kg bwt PJ.
Figure 7 Immunohistochemical expression of caspase-3 and NF-ĸB protein in the kidney tissue sections in different groups showing (A and B) mild to negative caspase-3 and NF-ĸB protein expression in control negative group. (C and D) Moderate positive caspase-3 and extensive nuclear translocation of NF-ĸB protein within the renal tubular epithelial cells in the group intoxicated with CuO-NPs. (E and F) Mild to moderate positive caspase-3 and NF-ĸB protein expression in group pretreated with 1 mL/ kg bwt PJ. (G and H) Mild to negative caspase-3 and NF-ĸB protein expression in group treated with 3 mL/kg bwt PJ.
